1. Rinella ME, Lazarus JV, Ratziu V, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol 2023; 79: 1542-1556.
2.
Younossi ZM, Golabi P, Paik JM, et al. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology 2023; 77: 1335-1347.
3.
Stepanova M, Kabbara K, Mohess D, et al. Nonalcoholic steatohepatitis is the most common indication for liver transplantation among the elderly: Data from the United States Scientific Registry of Transplant Recipients. Hepatol Commun 2022; 6: 1506-1515.
4.
Younossi Z, Tacke F, Arrese M, et al. Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Hepatology 2019; 69: 2672-2682.
5.
Geier A, Rinella ME, Balp MM, et al. Real-world burden of nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol 2021; 19: 1020-1029.e7.
6.
Cortesi PA, Conti S, Scalone L, et al. Health related quality of life in chronic liver diseases. Liver Int 2020; 40: 2630-2642.
7.
Kuraji R, Sekino S, Kapila Y, et al. Periodontal disease-related nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: An emerging concept of oral-liver axis. Periodontol 2000 2021; 87: 204-240.
8.
Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet 2005; 366: 1809-1820.
9.
Costa FO, Lages EJP, Lages EMB, et al. Periodontitis in individuals with liver cirrhosis: A case-control study. J Clin Periodontol 2019; 46: 991-998.
10.
Atchison KA, Dolan TA. Development of the Geriatric Oral Health Assessment Index. J Dent Educ 1990; 54: 680-687.
11.
Greene JC. The simplified oral hygiene index. J Am Dent Assoc 1964; 68: 7-13.
12.
D’Agostino S, Valentini G, Dolci M, et al. Potential relationship between poor oral hygiene and MRONJ: An observational retrospective study. Int J Environ Res Public Health 2023; 20: 5402.
13.
Van Tornout M, Dadamio J, Coucke W, et al. Tongue coating: related factors. J Clin Periodontol 2013; 40: 180-185.
14.
Shimizu T, Ueda T, Sakurai K. New method for evaluation of tongue-coating status. J Oral Rehabil 2007; 34: 442-447.
15.
Nesse W, Abbas F, van der Ploeg I, et al. Periodontal inflamed surface area: quantifying inflammatory burden. J Clin Periodontol 2008; 35: 668-673.
16.
Minakuchi S, Tsuga K, Ikebe K, et al. Oral hypofunction in the older population: Position paper of the Japanese Society of Gerodontology in 2016. Gerodontology 2018; 35: 317-324.
17.
Azogui-Levy S, Dray-Spira R, Attal S, et al. Factors associated with oral health-related quality of life in patients with diabetes. Aust Dent J 2018; 63: 163-169.
18.
Laouali N, El Fatouhi D, Aguayo G, et al. Type 2 diabetes and its characteristics are associated with poor oral health: findings from 60,590 senior women from the E3N study. BMC Oral Health 2021; 21: 315.
19.
Naser MY, Momani M, Naser AY, et al. Oral health profile and periodontal diseases awareness and knowledge among the Jordanian population: a cross-sectional study. BMC Oral Health 2023; 23: 503.
20.
Gerritsen AE, Allen PF, Witter DJ, et al. Tooth loss and oral health-related quality of life: a systematic review and meta-analysis. Health Qual Life Outcomes 2010; 8: 126.
21.
Rani V, Benjamin N, Abhilash A, et al. Oral health status, dietary intake, and oral health-related quality of life among institutionalized elderly in Bangalore. J Pharm Bioallied Sci 2024; 16 (Suppl 3): S2347-S2349.
22.
Mikami Y, Watanabe Y, Motokawa K, et al. Association between decrease in frequency of going out and oral function in older adults living in major urban areas. Geriatr Gerontol Int 2019; 19: 792-797.
23.
Almohamad M, Krall Kaye E, Mofleh D, et al. The association of sedentary behaviour and physical activity with periodontal disease in NHANES 2011-2012. J Clin Periodontol 2022; 49: 758-767.
24.
Stohr J, Barbaresko J, Neuenschwander M, et al. Bidirectional association between periodontal disease and diabetes mellitus: a systematic review and meta-analysis of cohort studies. Sci Rep 2021; 11: 13686.
25.
Uchida F, Oh S, Shida T, et al. Effects of exercise on the oral microbiota and saliva of patients with non-alcoholic fatty liver disease. Int J Environ Res Public Health 2021; 18: 3470.
26.
Molinsky RL, Johnson AJ, Marotz L, et al. Association between dietary patterns and subgingival microbiota: Results from the Oral Infections, Glucose Intolerance, and Insulin Resistance Study (ORIGINS). J Clin Periodontol 2025; 52: 2-15.
27.
Kamata Y, Kessoku T, Shimizu T, et al. Periodontal treatment and usual care for nonalcoholic fatty liver disease: A multicenter, randomized controlled trial. Clin Transl Gastroenterol 2022; 13: e00520.
28.
Saito A, Hosaka Y, Kikuchi M, et al. Effect of initial periodontal therapy on oral health-related quality of life in patients with periodontitis in Japan. J Periodontol 2010; 81: 1001-1009.
29.
Nowjack-Raymer RE, Sheiham A. Numbers of natural teeth, diet, and nutritional status in US adults. J Dent Res 2007; 86: 1171-1175.
30.
Wang L, Ding C, Zeng F, et al. Low levels of serum β-carotene and β-carotene/retinol ratio are associated with histological severity in nonalcoholic fatty liver disease patients. Ann Nutr Metab 2019; 74: 156-164.
31.
Chen HK, Luo J, Li XJ, et al. Serum folate associated with nonalcoholic fatty liver disease and advanced hepatic fibrosis. Sci Rep 2023; 13: 12933.
32.
Maeda H, Miura K, Aizawa K, et al. Apomorphine suppresses the progression of steatohepatitis by inhibiting ferroptosis. Antioxidants (Basel) 2024; 13: 805.
33.
Akinkugbe AA, Slade GD, Barritt AS, et al. Periodontitis and non-alcoholic fatty liver disease, a population-based cohort investigation in the study of health in Pomerania. J Clin Periodontol 2017; 44: 1077-1087.
34.
Weintraub JA, Lopez Mitnik G, Dye BA. Oral diseases associated with nonalcoholic fatty liver disease in the United States.
35.
J Dent Res 2019; 98: 1219-1226.
36.
Mahajan R, Kulkarni R, Stoopler ET. Gastroesophageal reflux disease and oral health: A narrative review. Spec Care Dentist 2022; 42: 555-564.
37.
Yarandi SS, Srinivasan S. Diabetic gastrointestinal motility disorders and the role of enteric nervous system: current status and future directions. Neurogastroenterol Motil 2014; 26: 611-624.
38.
Suzuki K, Tamaki N, Kurosaki M, et al. Concordance between metabolic dysfunction-associated steatotic liver disease and nonalcoholic fatty liver disease. Hepatol Res 2024; 54: 600-605.
39.
Yamazaki K, Kato T, Tsuboi Y, et al. Oral pathobiont-induced changes in gut microbiota aggravate the pathology of nonalcoholic fatty liver disease in mice. Front Immunol 2021; 12: 766170.
Copyright: © Clinical and Experimental Hepatology. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/) enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.